ABVC BioPharma

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$2.26
Previous Close
$2.25
Day Range
$2.22-$2.26
52W Range
$0.40-$5.48
Market Cap
$56.1M
Shares Short
365,776

Financials

See more
Revenue (12 Mos)
$797,916
Revenue Growth (YoY)
104.5%
Gross Profit (12 Mos)
$797,916
Diluted EPS
-$0.28

News

See more

Yahoo Finance • 2 years ago

ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market

Yahoo Finance • 2 years ago

ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M

Yahoo Finance • 2 years ago

ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results

Yahoo Finance • 2 years ago

ABVC BioPharma Entered Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the Valuation of $667 Million

About

CEO
Dr. Uttam Yashwant Patil Ph.D.
CFO
Dr. Uttam Yashwant Patil Ph.D.
Address
44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
16